Tag Archives: Health Care

BIO Joins Partners for Healthy Dialogues

Jim Greenwood

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had the opportunity to ask Jim Greenwood, President and CEO of BIO, about why BIO joined the effort, the importance of collaboration and preparing for the Physician Payments Sunshine Act. “BIO and our members support transparency in the life science industry and in the relationships between industry and physicians. We also strongly believe in the value of such relationships for the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

National Traceability System Moves into Implementation

5616315608_dd9b7a55dd_b

Last week, President Obama signed into law the Drug Quality and Security Act (H.R. 3204), which created a single, uniform and national solution to safeguard the nation’s pharmaceutical supply chain against criminal counterfeiting. Inside Health Policy’s Alaina Busch highlighted implementation plans in this November 20 story, “Drug Security Bill Ushers In Compounder Market Shift, 10-Year Effort To Implement Rx Tracing,” which can be accessed here with a subscription. Below are details on implementation based on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

The Arrival of Actionable Personalized Medicine

kevin-davies115-76

The pace of implementation of next-generation sequencing (NGS) in a clinical context, which almost rivals the development of the technology over the past decade, is driving the cost of a full genome sequence down to just a few thousand dollars. Diagnostic companies and medical centers are now routinely offering comprehensive genome analysis, as evidenced by the recent report from Baylor College of Medicine in the New England Journal of Medicine on the first 250 patients Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

A Manhattan Project for Alzheimer’s Disease

James Greenwood STILL 5_EDIT

Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & CEO Jim Greenwood highlighted the need for our nation to think bigger about how we approach Alzheimer’s Disease. Greenwood called for a “Manhattan Project” to rally the country around addressing this growing health challenge.  He also noted that addressing Alzheimer’s Disease is the type of issue that could bring together elected officials on both sides of the aisle. As part Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , ,

Bridging Research to Cures: Summit for R&D Companies

admin-ajax copy

As human and animal health companies struggle to advance medical innovation while managing costs, the outsourcing of research and development functions has become a critical strategy for success. BioResearch Central provides the outsourcing resources needed to accelerate healthcare innovation, to reach patients faster. Born of the legacy of Marion Laboratories and supported by a highly experienced workforce, BioResearch Central companies provide a breadth of services including discovery, toxicology, bioanalytics, clinical trials, regulatory and commercial support. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,